Terms: = Endocrine gland cancer AND PR, PGR, progesterone receptor AND Diagnosis
222 results:
1. [A Case Report of Metastatic Breast cancer with Peritoneal Metastasis and Massive Ascites Responding to CDK4/6 Inhibitor(Palbociclib)].
Yao S; Goi T; Takahashi M; Kono H; Yokoi S; Maeda H
Gan To Kagaku Ryoho; 2024 Feb; 51(2):214-216. PubMed ID: 38449417
[TBL] [Abstract] [Full Text] [Related]
2. Mesonephric-like adenocarcinoma of the ovary.
Yang Y; Zhao M; Jia Q; Tang H; Xing T; Li Y; Tang B; Xu L; Wei W; Zheng H; Shi R; Xia B; Chen J
J Ovarian Res; 2024 Mar; 17(1):57. PubMed ID: 38444000
[TBL] [Abstract] [Full Text] [Related]
3. The management of uterine tumor resembling an ovarian sex cord tumor (UTROSCT): case series and literature review.
Lin J; Liu L; Wang L; Ma N; Zhang K; Xie N; Yu H; Deng S; Sun Y
World J Surg Oncol; 2024 Feb; 22(1):42. PubMed ID: 38310233
[TBL] [Abstract] [Full Text] [Related]
4. High-grade HER2-positive mucoepidermoid carcinoma of the breast: a case report and review of the literature.
Mura MD; Clement C; Foschini MP; Vander Borght S; Waumans L; Van Eyken P; Hauben E; Keupers M; Weltens C; Smeets A; Nevelsteen I; Floris G
J Med Case Rep; 2023 Dec; 17(1):527. PubMed ID: 38062474
[TBL] [Abstract] [Full Text] [Related]
5. A Case of Uterine Tumor Resembling Ovarian Sex Cord Tumor With Prominent Myxoid Features.
Ise K; Tanei ZI; Oda Y; Tanikawa S; Sugino H; Ishida Y; Tsuda M; Gotoda Y; Nishiwaki K; Yanai H; Hasegawa T; Nagashima K; Tanaka S
Int J Gynecol Pathol; 2024 Jan; 43(1):41-46. PubMed ID: 37406360
[TBL] [Abstract] [Full Text] [Related]
6. High-grade Serous Carcinoma can Show Squamoid Morphology Mimicking True Squamous Differentiation.
Tomonobe H; Ohishi Y; Hachisuga K; Yahata H; Kato K; Oda Y
Am J Surg Pathol; 2023 Sep; 47(9):967-976. PubMed ID: 37382102
[TBL] [Abstract] [Full Text] [Related]
7. Male Accessory Breast cancer Successfully Treated With Single-Agent Trastuzumab: A Case Report.
Ji W; Guo W
Am J Mens Health; 2023; 17(3):15579883231171010. PubMed ID: 37218572
[TBL] [Abstract] [Full Text] [Related]
8. Novel therapeutics in low-grade serous ovarian cancer.
Cobb L; Gershenson D
Int J Gynecol Cancer; 2023 Mar; 33(3):377-384. PubMed ID: 36878564
[TBL] [Abstract] [Full Text] [Related]
9. A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors.
Němejcová K; Šafanda A; Bártů MK; Michálková R; Drozenová J; Fabian P; Hausnerová J; Laco J; Matěj R; Méhes G; Škapa P; Stružinská I; Dundr P
Diagn Pathol; 2023 Feb; 18(1):32. PubMed ID: 36855066
[TBL] [Abstract] [Full Text] [Related]
10. cancer-cell-derived sialylated IgG as a novel biomarker for predicting poor pathological response to neoadjuvant therapy and prognosis in pancreatic cancer.
Cui M; Shoucair S; Liao Q; Qiu X; Kinny-Köster B; Habib JR; Ghabi EM; Wang J; Shin EJ; Leng SX; Ali SZ; Thompson ED; Zimmerman JW; Shubert CR; Lafaro KJ; Burkhart RA; Burns WR; Zheng L; He J; Zhao Y; Wolfgang CL; Yu J
Int J Surg; 2023 Feb; 109(2):99-106. PubMed ID: 36799816
[TBL] [Abstract] [Full Text] [Related]
11. Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian cancer.
Penson RT; Ambrosio AJ; Whalen CA; Krasner CN; Konstantinopoulos PA; Bradley C; Matulonis UA; Birrer MJ
Oncologist; 2023 Mar; 28(3):252-257. PubMed ID: 36718018
[TBL] [Abstract] [Full Text] [Related]
12. Incidence and prevalence of drugs used for chronic diseases in survivors of adult-onset gynaecological cancer - A nationwide cohort study.
Bjørge T; Hjellvik V; Bjørge L; Dos-Santos-Silva I; Furu K; Kvåle R; Engeland A
BJOG; 2023 Jun; 130(7):770-778. PubMed ID: 36700296
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic medullary thyroid carcinoma (MTC): disease course, treatment modalities and factors predisposing for drug resistance.
Saltiki K; Simeakis G; Karapanou O; Paschou SA; Alevizaki M
Endocrine; 2023 Jun; 80(3):570-579. PubMed ID: 36626081
[TBL] [Abstract] [Full Text] [Related]
14. Application of deep learning as an ancillary diagnostic tool for thyroid FNA cytology.
Hirokawa M; Niioka H; Suzuki A; Abe M; Arai Y; Nagahara H; Miyauchi A; Akamizu T
Cancer Cytopathol; 2023 Apr; 131(4):217-225. PubMed ID: 36524985
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathologic Features and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas.
Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A
Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965
[TBL] [Abstract] [Full Text] [Related]
16. Genomic profiling in low grade serous ovarian cancer: Identification of novel markers for disease diagnosis and therapy.
ElNaggar A; Robins D; Baca Y; Arguello D; Ulm M; Arend R; Mantia-Smaldone G; Chu C; Winer I; Holloway R; Krivak T; Jones N; Galvan-Turner V; Herzog TJ; Brown J
Gynecol Oncol; 2022 Nov; 167(2):306-313. PubMed ID: 36229265
[TBL] [Abstract] [Full Text] [Related]
17. [A Case of Stage Ⅳ Pancreatic Head cancer with Aortic Lymph Node Metastasis Treated with 40 Courses of mFOLFIRINOX Therapy after Surgery and Maintaining PR].
Takahashi Y; Minoura H; Fujio T; Maruyama M; Soeno T; Chino S; Nakamura K; Kondo Y; Nishi Y; Kumamoto Y
Gan To Kagaku Ryoho; 2022 Sep; 49(9):973-976. PubMed ID: 36156017
[TBL] [Abstract] [Full Text] [Related]
18. [Clinical characteristics of patients with Breast and / or Ovarian cancer with mutations in the BRCA1 and BRCA2 genes in Córdoba, Argentina].
Martin CA; Suárez Villasmil L; Sembaj A; Gomez Balangione F; Zunino S; Montes CDC; Borello A; Del Castillo A; Zeballos M; Rossi NT
Rev Fac Cien Med Univ Nac Cordoba; 2022 Sep; 79(3):228-234. PubMed ID: 36149077
[TBL] [Abstract] [Full Text] [Related]
19. Post-recurrence survival analysis of patients with pulmonary recurrence from gynaecologic cancers: a multi-institutional analysis of 122 patients.
Ersak B; Akar S; Demirayak G; Tokalioğlu AA; Aytekin O; Çakir C; Yüksel D; Tokgözoğlu N; Karakaş S; Önder AB; Çelik F; Ayhan S; Ünsal M; Boran N; Kiliç F; Cömert GK; Üreyen I; Toptaş T; Korkmaz V; Özdemir İA; Taşçi T; Türkmen O; Moraloğlu Tekin Ö; Engin-Üstün Y; Turan T
J Obstet Gynaecol; 2022 Oct; 42(7):3277-3284. PubMed ID: 36000815
[TBL] [Abstract] [Full Text] [Related]
20. Sequential therapy for pancreatic cancer patients with synchronous oligo-hepatic metastatic lesions.
Lu W; Wang L; Lou J; Tang K
Tumori; 2023 Jun; 109(3):307-313. PubMed ID: 35815545
[TBL] [Abstract] [Full Text] [Related]
[Next]
